Overview
- 7 public-safe observations are available for this inspection.
- 7 structured CFR citations are represented.
- 4 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
Training of personnel
Cited by Shelley H Beausoleil, Eric Zhu, Conor J Mccarron, Deepa E Vadakkan
Use prior to verification
Cited by Shelley H Beausoleil, Eric Zhu, Conor J Mccarron, Deepa E Vadakkan
Investigation of adverse reactions
Cited by Shelley H Beausoleil, Eric Zhu, Conor J Mccarron, Deepa E Vadakkan
Design of procedures to ensure compliance
Cited by Shelley H Beausoleil, Eric Zhu, Conor J Mccarron, Deepa E Vadakkan
Adopting procedures from another organization
Cited by Shelley H Beausoleil, Eric Zhu, Conor J Mccarron, Deepa E Vadakkan
Inspected site
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 1271.160(b)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.210(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.350(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.47(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.47(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.75(a)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 1271.80(c) | Cited across public-safe Form 483 observations | 1x |
Source document
Form 483 source document
The source document is available to authorized Atlas users.
Full 483 report
Get the verbatim text of all 7 observations
The source PDF, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere